Browsing by Author "Yellon, Derek M."

Now showing items 1-2 of 2

    • Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent ... 
      Riquelme, Jaime; Westermeier, Francisco; Hall, Andrew R.; Vicencio, Jose; Pedrozo Cibils, Zully; Ibacache, Mauricio; Fuenzalida, Barbara; Sobrevia, Luis; Davidson, Sean M.; Yellon, Derek M.; Sánchez, Gina; Lavandero González, Sergio (Elsevier, 2016)
      The alpha2-adrenergic receptor agonist Dexmedetomidine (Dex) is a sedative medication used by anesthesiologists. Dex protects the heart against ischemia-reperfusion (IR) and can also act as a preconditioning mimetic. The ...
    • Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated ... 
      Kalkhoran, Siavash Beikoghli; Kriston-Vizi, Janos; Hernández Resendiz, Sauri; Crespo Avilan, Gustavo E.; Rosdah, Ayeshah A.; Lees, Jarmon G.; Simoes Da Costa, Joanna Rodrigues; Ling, Naomi X. Y.; Holien, Jessica K.; Samangouei, Parisa; Chinda, Kroekkiat; Yap, En Ping; Riquelme Meléndez, Jaime Andrés; Ketteler, Robin; Yellon, Derek M.; Lim, Shiang Y.; Hausenloy, Dereck J. (Oxford University Press, 2022)
      Aims Genetic and pharmacological inhibition of mitochondrial fission induced by acute myocardial ischaemia/reperfusion injury (IRI) has been shown to reduce myocardial infarct size. The clinically used anti-hypertensive ...